Literature DB >> 28710279

UbMES and UbFluor: Novel probes for ring-between-ring (RBR) E3 ubiquitin ligase PARKIN.

Sungjin Park1, Peter K Foote2, David T Krist2, Sarah E Rice1, Alexander V Statsyuk3,4.   

Abstract

Ring-between-ring (RBR) E3 ligases have been implicated in autoimmune disorders and neurodegenerative diseases. The functions of many RBR E3s are poorly defined, and their regulation is complex, involving post-translational modifications and allosteric regulation with other protein partners. The functional complexity of RBRs, coupled with the complexity of the native ubiquitination reaction that requires ATP and E1 and E2 enzymes, makes it difficult to study these ligases for basic research and therapeutic purposes. To address this challenge, we developed novel chemical probes, ubiquitin C-terminal fluorescein thioesters UbMES and UbFluor, to qualitatively and quantitatively assess the activity of the RBR E3 ligase PARKIN in a simple experimental setup and in real time using fluorescence polarization. First, we confirmed that PARKIN does not require an E2 enzyme for substrate ubiquitination, lysine selection, and polyubiquitin chain formation. Second, we confirmed that UbFluor quantitatively detects naturally occurring activation states of PARKIN caused by Ser65 phosphorylation (pPARKIN) and phosphorylated ubiquitin (pUb). Third, we showed that both pUb and the ubiquitin-accepting substrate contribute to maximal pPARKIN ubiquitin conjugation turnover. pUb enhances the transthiolation step, whereas the substrate clears the pPARKIN∼Ub thioester intermediate. Finally, we established that UbFluor can quantify activation or inhibition of PARKIN by structural mutations. These results demonstrate the feasibility of using UbFluor for quantitative studies of the biochemistry of RBR E3s and for high-throughput screening of small-molecule activators or inhibitors of PARKIN and other RBR E3 ligases.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Parkinson disease; UbFluor; enzyme; enzyme mechanism; parkin; ubiquitin

Mesh:

Substances:

Year:  2017        PMID: 28710279      PMCID: PMC5633118          DOI: 10.1074/jbc.M116.773200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  71 in total

1.  Site-specific Interaction Mapping of Phosphorylated Ubiquitin to Uncover Parkin Activation.

Authors:  Koji Yamano; Bruno B Queliconi; Fumika Koyano; Yasushi Saeki; Takatsugu Hirokawa; Keiji Tanaka; Noriyuki Matsuda
Journal:  J Biol Chem       Date:  2015-08-10       Impact factor: 5.157

2.  Diverse effects of pathogenic mutations of Parkin that catalyze multiple monoubiquitylation in vitro.

Authors:  Noriyuki Matsuda; Toshiaki Kitami; Toshiaki Suzuki; Yoshikuni Mizuno; Nobutaka Hattori; Keiji Tanaka
Journal:  J Biol Chem       Date:  2005-12-08       Impact factor: 5.157

3.  Parkin-catalyzed ubiquitin-ester transfer is triggered by PINK1-dependent phosphorylation.

Authors:  Masahiro Iguchi; Yuki Kujuro; Kei Okatsu; Fumika Koyano; Hidetaka Kosako; Mayumi Kimura; Norihiro Suzuki; Shinichiro Uchiyama; Keiji Tanaka; Noriyuki Matsuda
Journal:  J Biol Chem       Date:  2013-06-10       Impact factor: 5.157

4.  Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.

Authors:  Sathya R Sriram; Xiaojie Li; Han Seok Ko; Kenny K K Chung; Esther Wong; Kah Leong Lim; Valina L Dawson; Ted M Dawson
Journal:  Hum Mol Genet       Date:  2005-07-27       Impact factor: 6.150

5.  Ubiquitin is phosphorylated by PINK1 to activate parkin.

Authors:  Fumika Koyano; Kei Okatsu; Hidetaka Kosako; Yasushi Tamura; Etsu Go; Mayumi Kimura; Yoko Kimura; Hikaru Tsuchiya; Hidehito Yoshihara; Takatsugu Hirokawa; Toshiya Endo; Edward A Fon; Jean-François Trempe; Yasushi Saeki; Keiji Tanaka; Noriyuki Matsuda
Journal:  Nature       Date:  2014-06-04       Impact factor: 49.962

6.  Autoregulation of Parkin activity through its ubiquitin-like domain.

Authors:  Viduth K Chaugule; Lynn Burchell; Kathryn R Barber; Ateesh Sidhu; Simon J Leslie; Gary S Shaw; Helen Walden
Journal:  EMBO J       Date:  2011-06-21       Impact factor: 11.598

7.  Structure of a ubiquitin-loaded HECT ligase reveals the molecular basis for catalytic priming.

Authors:  Elena Maspero; Eleonora Valentini; Sara Mari; Valentina Cecatiello; Paolo Soffientini; Sebastiano Pasqualato; Simona Polo
Journal:  Nat Struct Mol Biol       Date:  2013-05-05       Impact factor: 15.369

8.  Label free fragment screening using surface plasmon resonance as a tool for fragment finding - analyzing parkin, a difficult CNS target.

Authors:  Karin Regnström; Jiangli Yan; Lan Nguyen; Kari Callaway; Yanli Yang; Linnea Diep; Weimei Xing; Anirban Adhikari; Paul Beroza; Roy K Hom; Brigit Riley; Don Rudolph; Michael F Jobling; Jeanne Baker; Jennifer Johnston; Andrei Konradi; Michael P Bova; Dean R Artis; Rick D Artis
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

9.  Structural basis for ligase-specific conjugation of linear ubiquitin chains by HOIP.

Authors:  Benjamin Stieglitz; Rohini R Rana; Marios G Koliopoulos; Aylin C Morris-Davies; Veronique Schaeffer; Evangelos Christodoulou; Steven Howell; Nicholas R Brown; Ivan Dikic; Katrin Rittinger
Journal:  Nature       Date:  2013-10-20       Impact factor: 49.962

10.  Structure of HHARI, a RING-IBR-RING ubiquitin ligase: autoinhibition of an Ariadne-family E3 and insights into ligation mechanism.

Authors:  David M Duda; Jennifer L Olszewski; Jonathan P Schuermann; Igor Kurinov; Darcie J Miller; Amanda Nourse; Arno F Alpi; Brenda A Schulman
Journal:  Structure       Date:  2013-05-23       Impact factor: 5.006

View more
  12 in total

1.  Monitoring PARKIN RBR Ubiquitin Ligase Activation States with UbFluor.

Authors:  Peter K Foote; Alexander V Statsyuk
Journal:  Curr Protoc Chem Biol       Date:  2018-07-31

Review 2.  Building and decoding ubiquitin chains for mitophagy.

Authors:  J Wade Harper; Alban Ordureau; Jin-Mi Heo
Journal:  Nat Rev Mol Cell Biol       Date:  2018-01-23       Impact factor: 94.444

3.  In vitro and in vivo characterization of erythrosin B and derivatives against Zika virus.

Authors:  Zhong Li; Jimin Xu; Yuekun Lang; Xiangmeng Wu; Saiyang Hu; Subodh Kumar Samrat; Anil M Tharappel; Lili Kuo; David Butler; Yongcheng Song; Qing-Yu Zhang; Jia Zhou; Hongmin Li
Journal:  Acta Pharm Sin B       Date:  2021-10-22       Impact factor: 14.903

Review 4.  Mitochondrial Miro GTPases coordinate mitochondrial and peroxisomal dynamics.

Authors:  Konrad E Zinsmaier
Journal:  Small GTPases       Date:  2020-11-12

Review 5.  Decoding the messaging of the ubiquitin system using chemical and protein probes.

Authors:  Lukas T Henneberg; Brenda A Schulman
Journal:  Cell Chem Biol       Date:  2021-04-07       Impact factor: 8.116

6.  Miro proteins prime mitochondria for Parkin translocation and mitophagy.

Authors:  Dzhamilja Safiulina; Malle Kuum; Vinay Choubey; Nana Gogichaishvili; Joanna Liiv; Miriam A Hickey; Michal Cagalinec; Merle Mandel; Akbar Zeb; Mailis Liiv; Allen Kaasik
Journal:  EMBO J       Date:  2018-11-30       Impact factor: 11.598

Review 7.  How to Target Viral and Bacterial Effector Proteins Interfering with Ubiquitin Signaling.

Authors:  Gerbrand J van der Heden van Noort; Huib Ovaa
Journal:  Curr Top Microbiol Immunol       Date:  2019       Impact factor: 4.291

Review 8.  Protein Engineering in the Ubiquitin System: Tools for Discovery and Beyond.

Authors:  Bo Zhao; Yien Che Tsai; Bo Jin; Bufan Wang; Yiyang Wang; Han Zhou; Tomaya Carpenter; Allan M Weissman; Jun Yin
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

9.  Mechanism of parkin activation by PINK1.

Authors:  Christina Gladkova; Sarah L Maslen; J Mark Skehel; David Komander
Journal:  Nature       Date:  2018-06-06       Impact factor: 49.962

10.  A High-Throughput Assay for Monitoring Ubiquitination in Real Time.

Authors:  Tyler G Franklin; Jonathan N Pruneda
Journal:  Front Chem       Date:  2019-12-04       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.